Poviyodo

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Poviyodo

Poviyodo is a medicine containing the active ingredient Povidone-iodine (PVP-I), which is categorized as a broad-spectrum microbicide and an antiseptic. Its primary function is topical antisepsis, making it a key agent for general prophylactic infection control. The active ingredient is a recognized medicinal component included on the international List of Essential Medicines.

Property Description
Active ingredient Povidone-iodine (PVP-I)
Form Topical Solution, Ointment
Pharmacological class Antiseptic / Iodophor
Common use Prophylactic infection control
Origin Synthetic polymer complex

What Type of Medicine is Poviyodo?

Poviyodo is a topical antiseptic and disinfectant compound used to destroy or inhibit the growth of microorganisms on living tissue or inanimate surfaces. Povidone-iodine is categorized as a microbicidal agent due to its ability to kill a vast range of pathogens.

The core medicinal entity is a synthetic complex derived from binding elemental iodine to the water-soluble carrier, polyvinylpyrrolidone (PVP). This chemical structure is its distinctive feature, as it allows the antiseptic action of iodine to be utilized with a lower risk of local irritation compared to traditional iodine tinctures. The agent is typically available over-the-counter (OTC) for accessibility in first-aid kits.

Composition and Forms of Povidone Iodine

The active ingredient is Povidone-iodine, which is typically presented in various topical preparations for application to the skin or mucosal surfaces. These formulations commonly include aqueous solutions for cleansing and swabbing, as well as an ointment for sustained local contact on minor wounds.

Poviyodo is considered a single active ingredient product, with the Povidone molecule functioning as the inert vehicle necessary to stabilize and control the release of the active germ-killing component, the free iodine. This complex is utilized as a topical antimicrobial agent for pre-surgical skin preparation.

How Povidone Iodine Provides Broad-Spectrum Protection

Povidone Iodine provides its protective action by slowly releasing free iodine when applied, which penetrates and kills microbial cells. This mechanism results in a cidal effect against a wide array of pathogens. The term broad-spectrum means this agent is effective against bacteria, fungi, viruses, and microbial spores, offering comprehensive decontamination.

What side effects are possible with Poviyodo?

Possible side effects and safety information for Poviyodo

The safety profile of Poviyodo (Povidone-iodine) is based on classifications from international regulatory bodies, detailing the adverse reactions by frequency and the organ systems potentially involved.

Officially Documented Adverse Reactions

The most frequent adverse events are classified as common and are generally localized. These include local skin irritation, redness (erythema), and a transient, reversible brown coloration at the site of application.

Less frequently observed adverse reactions, classified as uncommon or rare, involve immune system disorders, specifically hypersensitivity reactions such as contact dermatitis (allergic or irritant). Acute, generalized allergic reactions, including anaphylactic reaction, are considered very rare serious adverse events.

System-Organ Class Involved Key Adverse Event Type
Skin and Subcutaneous Tissue Local irritation, dermatitis, erythema
Immune System Hypersensitivity reactions, angioedema
Endocrine System Thyroid dysfunction (Hypo- or Hyperthyroidism)

Safety Constraints and Special Populations

Regulatory documentation highlights the risk of systemic iodine absorption, which is primarily associated with prolonged use or application over extensive body surfaces (e.g., severe burns). This systemic uptake can lead to disorders of the Endocrine System, specifically iodine-induced thyroid dysfunction.

Specific safety considerations apply to certain populations. Neonates and infants are at an elevated risk of developing hypothyroidism due to high skin permeability and immature thyroid function. Likewise, individuals with pre-existing thyroid disorders (e.g., hyperthyroidism) are constrained from using the medicine due to the increased risk of exacerbating their condition.

Regulatory restrictions also note that systemic iodine absorption may interfere with thyroid function tests, such as radioiodine diagnostics.

Overdose and Emergency Response

Poviyodo overdose manifestations are documented as resulting from excessive systemic absorption of iodine, typically following ingestion or extensive application on compromised skin. Officially recognized signs include corrosive effects in the gastrointestinal tract, which may present as vomiting, bloody diarrhoea, and abdominal pain. Systemic manifestations include fever and severe metabolic abnormalities, specifically metabolic acidosis and hypernatraemia.

Overdose may lead to severe, potentially life-threatening outcomes documented in official labeling, such as acute renal failure and circulatory collapse or shock. Systemic iodine overload can also result in critical effects on the endocrine system, causing hypothyroidism or hyperthyroidism. There is no specific antidote known for iodine poisoning; management is officially described as symptomatic and supportive.

Regulatory authorities mandate that if Poviyodo is swallowed, immediate medical help must be sought or a Poison Control Center contacted right away. Management requires continuous monitoring of vital signs, fluid balance, and kidney and thyroid function. Specific populations are at elevated risk: neonates have a documented increased susceptibility to developing hypothyroidism, and individuals with existing thyroid disease may develop hyperfunction.

Therapeutic Uses of Poviyodo

What Poviyodo Treats: Main Uses and Benefits

Poviyodo (Povidone-iodine) is a topical antiseptic that is applied across domains where additional symptomatic support is needed. As such, the agent is relevant in situations that involve a risk of infection.

The medicine is commonly used to help with symptoms related to inflammatory or irritative states when short-term symptomatic assistance is needed. This is relevant for managing symptoms that interfere with daily comfort arising from minor cuts, scrapes, abrasions, and superficial burns. It is applied across domains where additional symptomatic support is needed for pre-procedural care, and in conditions where symptoms may intensify temporarily, such as chronic skin defects like pressure ulcers.

This therapeutic focus helps ease the overall symptom burden by being relevant in contexts involving heightened systemic burden, contributing to improved comfort during symptomatic periods.


Quick Fact: Relief for Infection Risk

The primary benefit is relevant when supportive symptom management is appropriate, supporting protocols for skin care in both acute and professional medical settings.

Regulatory References

  1. NIH DailyMed drug overview

Eligibility and Restrictions for Use

Who can and cannot use Poviyodo?

Eligibility for Poviyodo (Povidone-iodine) is strictly defined by regulatory documents, focusing primarily on the risk of systemic iodine absorption and its impact on the thyroid gland. The medicine is contraindicated and must not be used by specific populations due to these documented risks.

Absolute Contraindications

Use is prohibited for patients with:

  • Known hypersensitivity to iodine or povidone.
  • Hyperthyroidism or other manifest thyroid diseases.
  • Patients immediately before and after radioactive iodine therapy.
  • Pre-term infants.

Restricted or Conditional Use

Official labeling requires specific restrictions for other populations:

  • Neonates and Small Infants: Use must be strictly indicated and kept to the absolute minimum due to the high risk of developing hypothyroidism.
  • Pregnancy and Lactation: Use is allowed only if strictly indicated and must be the absolute minimum exposure.
  • Duration and Extent: The product should not be used for longer than 7 days or applied over large areas of the body, based on official regulatory warnings for OTC use.

Adults are the standard eligible population for labeled indications. Patients with renal impairment are advised to use the medicine with caution.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory documents describe interaction patterns for Poviyodo (Povidone-iodine) based on chemical incompatibility, pharmacodynamic risk, and systemic exposure conditions. Co-administration with mercury derivatives is formally contraindicated due to the documented risk of forming corrosive compounds, such as mercuric iodide.

Documented Pharmacodynamic and Chemical Incompatibilities

Interacting Substance/Class Regulatory Description of Interaction
Lithium therapy (Concurrent) Regular use should be avoided due to the risk of additive hypothyroidic effects in treated patients.
Octenidine-based antiseptics Must not be used concomitantly or immediately following application to prevent local chemical incompatibility and transient dark discoloration.
Enzymatic wound cleaners Concomitant use causes a mutual reduction or impairment of effectiveness for both preparations.
Hydrogen Peroxide, Silver, Taurolidine These compounds may interact, leading to a mutual reduction of antimicrobial effects.

Interaction with Diagnostics and Exposure

Application to large areas of skin, severe burns, or wounds may result in a notable systemic absorption of iodine. This exposure is officially documented to interfere with thyroid function tests, including scintigraphy, and can consequently preclude planned radioiodine therapy. Additionally, the oxidative properties may cause false-positive results when testing for occult blood or glucose using certain diagnostic reagents.

Mechanism of Action

How Poviyodo Works


Irreversible Oxidation and Non-Selective Molecular Targeting

The core mechanism involves the controlled release of free iodine ( I2) from its povidone carrier, acting as a highly reactive, non-specific oxidant. This I2 rapidly penetrates the microbial cell and initiates irreversible oxidation and iodination of essential macromolecules, including proteins, nucleotides, and lipids, leading to the simultaneous destruction of the pathogen's structural integrity and metabolic function.

Mechanism of Broad-Spectrum Cidal Action

This multimodal attack on fundamental cellular components ensures the mechanism is effective across a broad spectrum of pathogens, including bacteria, viruses, fungi, and spores. Because the action is chemical and non-selective, targeting multiple basic life processes, it is highly unlikely for microbes to evolve a defense mechanism that would render the agent functionally irrelevant. The cidal (killing) action, rather than static (inhibiting) action, is an intrinsic property of the oxidative mechanism.

Constraints on Oxidative Efficacy

The drug's mechanism is chemically susceptible to environmental constraints imposed by the application site. High concentrations of organic materials (such as blood, pus, or tissue proteins) will preferentially react with and consume the available free iodine. This chemical limitation results in a diminished concentration of the oxidant available to target microbes.

Dosage and Administration Information

Poviyodo, which contains the active ingredient Povidone-iodine, is administered exclusively via the topical route. The medicine is supplied as a topical solution and as an ointment, typically in concentrations of 7.5% or 10%. The dosing regimen falls into standard patterns based on the context of use.

For cleansing prior to medical procedures, the usage is a single application to the designated area. For first-aid applications, such as minor cuts and abrasions, the preparation is often applied up to three times daily, or as needed. In both contexts, the product is applied undiluted. A critical instruction for proper use is that the application site must be allowed to air dry completely before it is covered with a dressing or before a procedure begins.

The administration protocol mandates that Poviyodo is strictly for external use only and must not be swallowed. The usage is constrained to short-term courses, generally not exceeding seven consecutive days for self-managed treatment of minor wounds. Furthermore, special instructions for pediatric use include advising caution in neonates and very low birth weight infants. These domains—route, frequency, method, and duration—characterize the standardized use of the medicine.

Recent Clinical Evidence

Poviyodo: Recent Clinical Evidence


Evidence for Use in Prophylactic Skin and Mucosal Care

Research for prophylactic skin preparation uses Randomized Controlled Trials (RCTs) and meta-analyses to evaluate its application prior to procedures. Studies monitored outcomes like Surgical Site Infections (SSI) and immediate reduction in bacterial load on the skin. Studies reported measurements of infection and bacterial counts in adult patients undergoing various surgeries. Uncertainty exists regarding comparative certainty against other antiseptic solutions, as findings have been mixed. For some applications, the evidence relies on surrogate endpoints (bacterial reduction), meaning the acute measurement's connection to long-term clinical outcome is not always consistently characterized.


Evidence for Use in Topical Wound Antisepsis

Research has explored the use of Poviyodo for topical antisepsis in contexts such as minor cuts and abrasions. This use is often categorized as long-established, supported by In vitro studies that characterize its activity against microbes. Studies monitored outcomes related to the healing process in chronic skin defects. Contemporary, large-scale RCTs for simple first-aid applications are not common in the published literature, and limited information exists for long-term recurrence patterns.


Evidence for Supportive Care in Acute Self-Limiting Symptoms

Poviyodo was studied for some applications concerning acute self-limiting symptoms, such as those during a common cold, using short-term RCTs. The studies monitored patient-reported symptom severity scores and examined viral load/shedding measurements. Evidence is limited and heterogeneous, confined to specific delivery formats (e.g., nasal spray). Follow-up was short, meaning long-term effects are not fully established.


Long-Term Studies and Research Gaps

Long-term outcomes are not well characterized across all applications. Follow-up for surgical procedures is typically intermediate (up to three months), while acute symptom studies are short-term. The majority of primary clinical research was conducted on adults or healthy volunteers. Data for certain groups, such as children or specific patient groups with comorbidities, remain insufficient. Overall, evidence quality varies across studies, and data for long-term outcomes and under-represented groups requires more research.

Key Studies & References

  1. Comparative effectiveness of antiseptic skin preparations for surgical site infection prevention
  2. DailyMed Drug Label Information for Povidone-iodine

Frequently Asked Questions (FAQ)

Common questions about Poviyodo (FAQ)

Q: Is Poviyodo a kind of antibiotic or a different type of medicine?

A: According to official documents, Poviyodo is classified as an antiseptic and a broad-spectrum microbicide. This means its action is designed to destroy microorganisms on the skin or tissue surface. This mechanism of action is generally different from that of systemic antibiotics, which are medicines taken internally to fight infection.

Q: Is there a generic version of Poviyodo available?

A: The medicine's active compound is Povidone-iodine (PVP-I). This active ingredient name is the established generic compound for the medicine.

Q: Does the evidence indicate Poviyodo is for short-term or long-term use?

A: For general self-managed first-aid use, regulatory warnings advise that the product should not be used for longer than seven consecutive days. Prolonged use or application over large areas is associated with increased risk of systemic iodine absorption, according to official warnings.

Q: What should I do if a side effect seems serious?

A: Official warnings advise that use of the product should be stopped if the condition being treated persists or worsens. Official warnings state that a health care professional should be consulted if redness, irritation, swelling, or pain increases.

Q: How long does Poviyodo usually stay in the system?

A: When applied to intact skin, the systemic absorption of iodine from Poviyodo is generally considered to be negligible. Absorbed iodine is reported to be eliminated almost exclusively by the renal route (via the kidneys).

Q: Can Poviyodo be used by people of all ages?

A: The use of Poviyodo is generally indicated for adults and children 2 years and older. However, official warnings indicate that the product is contraindicated or subject to conditional use in pre-term infants, neonates, and children under two years of age for many formulations.

Q: Are there any common over-the-counter medicines that interact with Poviyodo?

A: Official prescribing documents note that Poviyodo is chemically incompatible with several substances. These include certain agents like mercury derivatives, Octenidine-based antiseptics, and preparations containing hydrogen peroxide.

Q: What should I know about the safety profile of Poviyodo?

A: The documented safety profile lists common local events, such as skin irritation and redness, as the most frequent reactions. The main systemic risk noted in official warnings is the possibility of thyroid dysfunction, which may occur due to iodine absorption following application over extensive areas or from prolonged use.

Q: What if I have an existing health condition; can I still use Poviyodo?

A: The medicine is officially contraindicated in patients with manifest thyroid diseases (like hyperthyroidism) and those immediately before or after radioactive iodine therapy. Caution is also officially advised for use in patients with pre-existing renal impairment (kidney problems).

Q: Are there different strengths of Poviyodo tablets?

A: According to official product information, Poviyodo is listed as a topical solution and ointment for external use. Tablet forms are not listed among the commonly approved or regulated formulations.

Q: Is Poviyodo related to any other medicines with similar names?

A: Poviyodo contains Povidone-iodine (PVP-I), which is categorized as an iodophor. This makes it chemically related to other complexes that are designed to slowly release the active antiseptic component, elemental iodine.

Q: Why do official sources list specific groups of people who should not use Poviyodo?

A: The official restrictions are primarily established due to the risk of systemic iodine absorption. This absorption can potentially cause thyroid dysfunction in vulnerable populations, such as fetuses, neonates, and infants, as iodine can pass through the placenta and be secreted in breast milk.

Q: What is the general long-term expectation for people using Poviyodo?

A: Regulatory documents restrict self-managed use to a maximum of seven days for general wound care. Furthermore, research indicates that long-term outcomes and effects are not well characterized across all approved applications.

Q: Does Poviyodo need to be taken at a specific time of day?

A: Official directions for use describe application frequency for first-aid care. However, the regulatory documentation does not specify a fixed or mandatory time of day for administration.

Q: Why is Poviyodo prescribed for seemingly different health issues?

A: The agent is categorized as a broad-spectrum microbicide due to its underlying mechanism of action. This broad spectrum means its active ingredient, free iodine, is effective against a wide range of pathogens, including bacteria, viruses, and fungi, allowing its use in various topical situations.

Q: Are there any known issues with taking Poviyodo before surgery?

A: The medicine is described in official documentation as being used for skin cleansing prior to medical procedures to prevent infection. However, its systemic absorption may be significant enough to interfere with subsequent thyroid function tests and could potentially preclude planned radioiodine therapy.

How should Poviyodo be stored and disposed of?

How to Store and Dispose of Poviyodo?

Poviyodo (Povidone-iodine) must be stored and handled according to the specific conditions detailed in its official regulatory labeling to maintain its stability and ensure safety.


Official Storage Requirements

Condition Requirement
Temperature Store at controlled room temperature (20 C to 25 C / 68 F to 77 F).
Environment Protect from light and avoid excessive heat. Do not freeze the product.
Packaging Keep the product in its original container and ensure the container is tightly closed when not in use.
Safety It is mandatory to keep Poviyodo out of the sight and reach of children.

Disposal Instructions

Unused or expired Poviyodo must be disposed of according to local regulations. The official method is to utilize an available drug take-back program (e.g., pharmacy or collection site). If a take-back program is unavailable, follow authorized household disposal procedures for non-hazardous medicines, which includes mixing the product with an unappealing substance and sealing it before discarding.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Poviyodo found in:

A-Z Index: